1-2 of 2
Hanna Knaus, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective Immunomodulation with Pomalidomide Beginning at Early Lymphocyte Recovery during Induction Timed Sequential Therapy (TST) for Acute Myeloid Leukemia (AML) and High-Risk Myelodysplasia (HR-MDS)

Joshua F Zeidner, MD, Hanna Knaus, MD, Amer M. Zeidan, MBBS, MHS, Amanda Blackford, Raul Montiel-Esparza, MD, Gabrielle T. Prince, MD, Lukasz P. Gondek, MD PhD, Gabriel Ghiaur, MD PhD, Margaret M. Showel, MD, Amy E. DeZern, MD, Keith W. Pratz, MD, B. Douglas Smith, MD, Mark J. Levis, MD, Matthew C Foster, MD, Catherine C. Coombs, MD, Howard Streicher, MD, Judith E. Karp, MD, Leo Luznik, MD, Ivana Gojo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 335.
https://doi.org/10.1182/blood-2018-99-114961
Published: 2018
Journal Articles

Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)

Tara M. Robinson, MD PhD, Hanna Knaus, MD, B Douglas Smith, MD, Andrea M.H. Towlerton, BS, Edus H. Warren, III, MDPhD, Joshua F Zeidner, MD, Amanda Blackford, Amy S. Duffield, MD PhD, David Rizzieri, MD, Mark G. Frattini, MD PhD, Moshe Levy, MD, Mark A. Schroeder, MD, Anna Ferguson, BSN, RN, Katherine Sheldon, Amy E. DeZern, MD, Ivana Gojo, MD, Steven D. Gore, MD, Howard Streicher, MD, Leo Luznik, MD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1699.
https://doi.org/10.1182/blood.V130.Suppl_1.1699.1699
Published: 2017